FGF18 and colorectal carcinoma: In terms of clinical survival prognosis of CRC, multivariate analysis of RNA-seq in 99 stage IV CRC patients predicted that FGF18 in CRC patients had significant changes in mRNA level and was significantly correlated with overall survival of CRC patients (60).